News

Trump’s entire negotiating philosophy was built on the premise that he could threaten economic chaos if other countries ...
The U.S. imports more pharmaceutical products from Ireland than from any other country -- nearly $50 billion last year. It won't be surprising if the Trump administration especially targets those ...
Potential US pharma import tariffs could raise prices, stifle innovation, and revolutionise how the industry produces drugs.
Ireland has become a major base for US pharma companies, including Pfizer, Eli Lilly and Johnson & Johnson. That’s bolstered the economies of individual towns and played a role in the country’s ...
The county joins municipalities across the country suing Eli Lilly, CVS Caremark, and others for sky-high prices.
Trump's EO aims to lower US drug prices by using leverage of public programs (like Medicare) to force accountability. Big ...
PhRMA, which gave $1 million to Trump's inaugural fund, warned against parts of Trump's drug pricing executive order.
Announcement pressures pharma stocks on worries profits will be hit if they have to cut prices in US. Read more at straitstimes.com. Read more at straitstimes.com.
Now, this won't come as too much of a surprise to Eli Lilly and its peers. A few weeks ago, the company's CEO, David Ricks, predicted that though Trump had spared the industry with tariffs ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...
Johnson & Johnson factored roughly $400 million into its 2025 guidance to account for the impact ... the Trump administration could unleash an even bigger threat than tariffs to AbbVie, Lilly ...
President Trump recently warned big drugmakers that ... the president warned that a "tariff wall" is coming. Although AbbVie, Eli Lilly, and Johnson & Johnson manufacture many of their products ...